0001193125-18-296135.txt : 20181109 0001193125-18-296135.hdr.sgml : 20181109 20181009183057 ACCESSION NUMBER: 0001193125-18-296135 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20181009 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Krystal Biotech, Inc. CENTRAL INDEX KEY: 0001711279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 810930882 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2100 WHARTON STREET STREET 2: SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 BUSINESS PHONE: (412) 586-5830 MAIL ADDRESS: STREET 1: 2100 WHARTON STREET STREET 2: SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 CORRESP 1 filename1.htm CORRESP

KRYSTAL BIOTECH, INC.

2100 Wharton Street, Suite 701

Pittsburgh, PA 15203

October 9, 2018

VIA EDGAR

Ms. Irene Paik

Division of Corporation Finance

United States Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

 

Re:

Krystal Biotech, Inc.

    

Registration Statement on Form S-3 (File No. 333-227632)

Dear Ms. Paik:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Krystal Biotech, Inc. (the “Registrant”) hereby requests acceleration of effectiveness of its registration statement on Form S-3 (File No. 333-227632) to 9:00 a.m., Eastern Time, on October 12, 2018, or as soon as practicable thereafter.

The Registrant requests that it be notified of such effectiveness by a telephone call to John W. Campbell, the Company’s counsel at Morrison & Foerster LLP, at (415) 268-7197.

 

Very truly yours,

 

Krystal Biotech, Inc.

By:  

/s/ Krish S. Krishnan

Name:   Krish S. Krishnan
Title:   President and Chief Executive Officer